Aspreva Pharmaceuticals' P2P Acquisition

Aspreva Pharmaceuticals raised a round of funding on December 18, 2007. Investors include Galenica Sante.

Aspreva identified, developed and commercialized new indications for approved drugs and late-stage drug candidates for patients living with uncommon diseases.…

Articles about Aspreva Pharmaceuticals' P2P Acquisition: